Recent Advances in Preclinical Studies of the Theranostic Agent [<sup>64</sup>Cu]CuCl<sub>2</sub>.

Molecules · 2024 · PMC11397388 · PMID 39274933

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Over time, the uptake of 64 Cu in the MDA-MB-231-hCTR1 tumor showed an increasing trend, whereas in the MDA-MB-231 tumor, it remained stable.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.